PRESS RELEASE published on 05/19/2025 at 14:01, 10 months 9 days ago Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback Tharimmune, Inc. appoints James Gordon Liddy as strategic advisor for TH104 development, targeting high-potency opioid exposure. FDA feedback positive for prophylaxis indication Tharimmune Inc. FDA Feedback High-Potency Opioids James Gordon Liddy TH104 Development
BRIEF published on 05/06/2025 at 14:06, 10 months 22 days ago Tharimmune Reports Positive Phase 1 Results for TH104 Tharimmune Inc. FDA Feedback Phase 1 Study Opioid Prophylaxis TH104 Buccal Film
BRIEF published on 05/06/2025 at 14:06, 10 months 22 days ago Tharimmune annonce des résultats positifs de phase 1 pour le TH104 Tharimmune Inc. Étude De Phase 1 Commentaires De La FDA Prophylaxie Aux Opioïdes Film Buccal TH104
PRESS RELEASE published on 05/06/2025 at 14:01, 10 months 22 days ago Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback Tharimmune, Inc. presents promising pharmacokinetic and metabolism data of TH104, a buccal film of nalmefene, for prophylaxis against opioid exposure. Study results showcased at Digestive Disease Week 2025 Tharimmune Inc. TH104 Buccal Film Pharmacokinetic Study Opioid Prophylaxis
BRIEF published on 05/01/2025 at 14:06, 10 months 27 days ago Le TH104 de Tharimmune sera présenté lors de conférences médicales importantes Biopharmaceutique TH104 Tharimmune DDW 2025 EASL 2025
BRIEF published on 05/01/2025 at 14:06, 10 months 27 days ago Tharimmune's TH104 to Be Presented at Notable Medical Conferences TH104 Biopharmaceutical Tharimmune DDW 2025 EASL 2025
PRESS RELEASE published on 05/01/2025 at 14:01, 10 months 27 days ago Tharimmune Abstracts Accepted for Presentation at Upcoming DDW and EASL Conferences Tharimmune, Inc. announces presentation of clinical data on lead drug TH104 at DDW and EASL Annual Meetings in May 2025, addressing unmet medical needs in immunology & inflammation Tharimmune Inc. TH104 Clinical Data Immunology Unmet Medical Needs
BRIEF published on 04/30/2025 at 14:06, 10 months 28 days ago Tharimmune élargit son conseil d'administration avec de nouvelles nominations Stratégie De Croissance Biopharmaceutique Direction Nominations Au Conseil D'administration Tharimmune
BRIEF published on 04/30/2025 at 14:06, 10 months 28 days ago Tharimmune Expands Board with New Appointments Growth Strategy Biopharmaceutical Leadership Board Appointments Tharimmune
PRESS RELEASE published on 04/30/2025 at 14:01, 10 months 28 days ago Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors Tharimmune, Inc. appoints Clay Kahler and Gary Stetz to its Board of Directors, expanding to 9 members. Kahler brings life sciences expertise while Stetz contributes financial acumen Board Of Directors Financial Expertise Tharimmune Clay Kahler Gary Stetz
Published on 03/28/2026 at 01:00, 15 hours 45 minutes ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 15 hours 50 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 15 hours 55 minutes ago "Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 18 hours ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 18 hours 15 minutes ago Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property
Published on 03/28/2026 at 10:05, 6 hours 40 minutes ago Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 7 hours 49 minutes ago Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 15 hours 3 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 18 hours 47 minutes ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 18 hours 47 minutes ago Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025
Published on 03/27/2026 at 19:06, 21 hours 39 minutes ago Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 18:52, 21 hours 53 minutes ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 21 hours 53 minutes ago Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025